Related references
Note: Only part of the references are listed.A Network Meta-Analysis Comparing Osteoporotic Fracture among Different Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation
Dibbendhu Khanra et al.
Journal of Bone Metabolism (2021)
Low rates of liver injury in edoxaban users: Evidence from a territory-wide observational cohort study
Jiandong Zhou et al.
CLINICAL CARDIOLOGY (2021)
Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease
Gary Tse et al.
JOURNAL OF HYPERTENSION (2021)
The association between blood pressure variability and hip or vertebral fracture risk: A population-based study
Jiandong Zhou et al.
BONE (2021)
Bone density and quality in patients treated with direct-acting oral anticoagulants versus warfarin
Jeferson Zanovelli Nalevaiko et al.
BONE (2021)
Development of a predictive risk model for all-cause mortality in patients with diabetes in Hong Kong
Sharen Lee et al.
BMJ OPEN DIABETES RESEARCH & CARE (2021)
Non-vitamin K oral anticoagulants and risk of fractures: a systematic review and meta-analysis
Pajaree Mongkhon et al.
EUROPACE (2021)
Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation
Pamela L. Lutsey et al.
JAMA INTERNAL MEDICINE (2020)
Fracture risks among patients with atrial fibrillation receiving a different oral anticoagulants: a real-world nationwide cohort study
Huei-Kai Huang et al.
EUROPEAN HEART JOURNAL (2020)
Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation A Population-Based Cohort Study
Wallis C. Y. Lau et al.
ANNALS OF INTERNAL MEDICINE (2020)
Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study
Huei-Kai Huang et al.
EUROPEAN HEART JOURNAL (2020)
Atrial fibrillation and risk of hip fracture: A population-based analysis of 113,600 individuals
Christopher X. Wong et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Osteoporotic Fractures Associated With Dabigatran vs Warfarin
Toshihiro Sugiyama
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation
Wallis C. Y. Lau et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation
Lindsay G. S. Bengtson et al.
JOURNAL OF CARDIOLOGY (2017)
Adverse bone effects of medications used to treat non-skeletal disorders
N. B. Watts
OSTEOPOROSIS INTERNATIONAL (2017)
Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling ENGAGE AF-TIMI 48 Analysis
Jan Steffel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Warfarin use and fracture risk: an evidence-based mechanistic insight
T. Sugiyama et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Differential Effects of Dabigatran and Warfarin on Bone Volume and Structure in Rats with Normal Renal Function
Maria Fusaro et al.
PLOS ONE (2015)
Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis
Sayaka Namba et al.
BBA CLINICAL (2015)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The effects of warfarin and edoxaban, an oral direct factor Xa inhibitor, on gammacarboxylated (Gla-osteocalcin) and undercarboxylated osteocalcin (uc-osteocalcin) in rats
Yoshiyuki Morishima et al.
THROMBOSIS RESEARCH (2013)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women
Pawel Szulc et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
Sebastian Schneeweiss et al.
EPIDEMIOLOGY (2009)
Fracture risk in users of oral anticoagulants: A nationwide case-control study
Lars Rejnmark et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
O. Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Risk of osteoporotic fracture in elderly patients taking warfarin - Results from the National Registry of Atrial Fibrillation 2
BF Gage et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Share Paper
